The Team Behind DermaClip

Our Company

DermaClip® US, L.L.C. believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The DermaClip® team's goal is to eliminate the trade-offs in skin closure made between time of closure and quality of patient care. The team aims to accomplish this goal by bringing the DermaClip® device to the US market and will further that goal with the continued development of non-invasive devices that enhance efficiencies and patient results.

The development of DermaClip® was the result of reviewing pre-existing knowledge of what ideally would be a perfect wound closure device and what the shortcomings were of existing techniques currently used. These findings were then combined with the medical knowledge of surgeons developed through years of experience closing wounds. Together, these surgeons conjured from their experience what a perfect wound closure device would be and what it would do.

This vision was brought experienced and creative engineer to combine their knowledge, experience and skills into a team to design an actual wound closure device – unlike any that had come before -- to address those shortcomings.  The result of that effort, which ultimately took years to develop, is the innovative, simple skin closure device called DermaClip®.

Medical Advisors

Jeffrey S. Freed
Chief Medical Officer
Chairman, Medical Advisory Board

Dr. Freed specializes in colon and rectal surgery and has 45 years of experience in the field. He is a Clinical Professor of Surgery at Ichan School of Medicine at Mount Sinai in New York and is also affiliated with the James J. Peters VA Medical Center in New York. He is a Fellow of the American College of Surgeons and of the American College of Gastroenterology and an Associate Clinical Professor at Mount Sinai School of Medicine in New York. Dr. Freed received his Medical Degree from the SUNY Downstate Medical Center College of Medicine, graduating with honors.


John Ko
Member, Medical Advisory Board

Dr. Ko specializes in Plastic and Reconstructive Surgery. He is Assistant Clinical Professor of Surgery at the Icahn School of Medicine at Mount Sinai in New York. He is also affiliated with the NewYork-Presbyterian/Hudson Valley Hospital, White Plains Hospital, and the James J. Peters VA Medical Center in New York. Dr. Ko received both his Medical Degree and a PhD in Biophysics from Boston University.


Thomas P. Sterry
Member, Medical Advisory Board

Dr. Sterry is a board certified plastic surgeon who has had a private practice since 2001. He is also an assistant clinical professor of plastic surgery at the Icahn School of Medicine at Mount Sinai Hospital in New York City, and an assistant professor at the Veterans Affairs Medical Center in Bronx, New York. Dr. Sterry is trained in cosmetic surgery, aesthetic and reconstructive breast surgery, craniofacial surgery, head and neck reconstruction, oncologic surgery, elective and traumatic hand surgery, burn surgery, microvascular surgery, laser surgery and reconstruction of the trunk and lower extremities. He is especially noted for his body contouring surgery after bariatric surgery and has been named one of the top plastic surgeons in America by the Consumers Research Council of America. He received his medical degree with distinction in research from Stony Brook University School of Medicine and holds a master of science degree in exercise physiology from Queens College of the City University of New York.


Mark L. Waltzman
Member, Medical Advisory Board

Dr. Waltzman specializes in Pediatric Emergency Medicine. He is a Senior Associate in Medicine, Boston Children’s Hospital; Chairman, South Shore Hospital's Department of Pediatrics; and Assistant Professor of Pediatrics, Harvard Medical School. He is a Fellow of the American Academy of Pediatrics. Dr. Waltzman received his Medical Degree from the University of Nevada.


Charles M. Darling, IV
President & CEO

Mr. Darling has been involved in project development and investment for over 30 years. Previously, he was President, General Counsel and Director of a publicly traded energy company, of which he was a founder and helped foster its growth from a start-up to a publicly-traded holding company with two publicly-traded subsidiaries that he subsequently helped manage the sale of to a major energy company. Mr. Darling practiced law for 25 years with Baker Botts, LLP. Mr. Darling has been working on developing projects nationally and internationally throughout most of his career. In addition, he has served as a director of three publicly traded companies, one of which he served on as Presiding Director and a member of the Audit and Compensation Committees. He has been actively involved in developing DermaClip®, taking the device from a late design stage to being able to be manufactured on a commercial basis. As well, he was integrally involved in sourcing suppliers and in the build-out of the manufacturing operations for the product.

John Berry
Chief Commercial Officer

Mr. Berry has spent over 30 years in the medical device industry. During this time, he has developed an expertise in growing sales teams and generating explosive market growth for a range of medical device and technology companies. Most recently, he was the President of Medevations, a company providing medical technology distribution focused on early stage technologies and consulting services supporting strategy, leadership, and sales process development. Prior to Medevations, Mr. Berry held several positions, including National Sales Director and Vice President of Surgical Oncology, with TissueLink Medical, a start-up that later became Salient Surgical Technologies until it was purchased by Medtronic in 2011.


Catherine Fonfara
Senior Vice President,
Finance & Legal

Ms. Fonfara worked in the legal area for 30 years, the last 12 of which were with Baker Botts, LLP. Prior to that she worked for a Prince of the Kingdom of Saudi Arabia, assisting him in his duties with the United Nations in Third-World countries. She became involved in the energy industry in the late 1980's and, thereafter, with project development with DQ Holdings. She has been involved with the development of DermaClip® since inception.


Christopher Darling
Vice President,
Business Development & Operations

Mr. Darling has worked in finance and business development roles for over 5 years. Most recently, he was an Assistant Vice President in BNP Paribas' Financial Institutions Group in London. Prior to that, he worked in BNP Paribas Fortis' Institutional Banking Group as the Head of Business Development and Strategy and was based out of the Brussels headquarters. He started his career with Deloitte Consulting in New York. Mr. Darling holds an MBA from The Wharton School.